Home » Analyst Articles – US

Telefonaktiebolaget LM Ericsson (ERIC) Upgraded to Buy by Bank of America

Bank of America upgraded shares of Telefonaktiebolaget LM Ericsson (NASDAQ:ERIC) from a neutral rating to a buy rating in a report published on Wednesday, Benzinga reports. Bank of America currently has $9.85 target price on the communications equipment provider’s stock. Other equities research analysts have also issued reports about the company. BidaskClub upgraded Telefonaktiebolaget LM Ericsson from a hold rating to a buy rating in a research report on Saturday, April 13th. ValuEngine lowered Telefonaktiebolaget LM Ericsson from a strong-buy... 
 

Orange (ORAN) Raised to “Hold” at Zacks Investment Research

Zacks Investment Research upgraded shares of Orange (NYSE:ORAN) from a sell rating to a hold rating in a report issued on Wednesday, Zacks.com reports. According to Zacks, “Orange SA provides telecommunications services. It offers a range of fixed telephony and mobile telecommunications, data transmission, Internet and multimedia, and other value-added services to consumers, businesses, and other telecommunications operators under the Orange brand worldwide. Orange SA, formerly known as France Telecom S.A., is based in Paris, France. “ A... 
 

Ryanair (RYAAY) Downgraded to Reduce at HSBC

HSBC downgraded shares of Ryanair (NASDAQ:RYAAY) from a hold rating to a reduce rating in a research note issued to investors on Wednesday, 24/7 WallStreet reports. RYAAY has been the topic of a number of other reports. BidaskClub upgraded Ryanair from a sell rating to a hold rating in a report on Tuesday, April 16th. ValuEngine upgraded Ryanair from a strong sell rating to a sell rating in a report on Monday, April 1st. Societe Generale upgraded Ryanair from a hold rating to a buy rating in a report on Tuesday, February 19th. Cantor Fitzgerald... 
 

Kalvista Pharmaceuticals (KALV) Downgraded by BidaskClub to “Hold”

BidaskClub cut shares of Kalvista Pharmaceuticals (NASDAQ:KALV) from a buy rating to a hold rating in a research report sent to investors on Wednesday morning, BidAskClub reports. KALV has been the topic of several other research reports. Needham & Company LLC assumed coverage on shares of Kalvista Pharmaceuticals in a report on Wednesday, March 20th. They issued a buy rating and a $35.00 price target on the stock. Roth Capital boosted their price target on shares of Kalvista Pharmaceuticals from $25.00 to $30.00 and gave the company a buy rating... 
 

United Natural Foods (UNFI) Stock Rating Upgraded by BidaskClub

BidaskClub upgraded shares of United Natural Foods (NASDAQ:UNFI) from a sell rating to a hold rating in a research report released on Wednesday, BidAskClub reports. A number of other equities research analysts have also issued reports on UNFI. Zacks Investment Research upgraded shares of United Natural Foods from a strong sell rating to a hold rating in a research note on Friday, February 8th. Loop Capital lowered their price objective on shares of United Natural Foods to $30.00 and set a buy rating for the company in a research report on Wednesday,... 
 

Halozyme Therapeutics (HALO) Downgraded by BidaskClub to Sell

BidaskClub downgraded shares of Halozyme Therapeutics (NASDAQ:HALO) from a hold rating to a sell rating in a research note published on Wednesday, BidAskClub reports. Several other brokerages have also recently issued reports on HALO. Zacks Investment Research raised Halozyme Therapeutics from a hold rating to a buy rating and set a $19.00 price objective on the stock in a research note on Tuesday, January 29th. Cantor Fitzgerald set a $24.00 price objective on Halozyme Therapeutics and gave the stock a buy rating in a research note on Thursday,... 
 

Union Bankshares (UNB) Rating Lowered to C+ at TheStreet

TheStreet lowered shares of Union Bankshares (NASDAQ:UNB) from a b- rating to a c+ rating in a research note published on Tuesday, TheStreetRatingsTable reports. Separately, ValuEngine downgraded shares of Union Bankshares from a hold rating to a sell rating in a research note on Tuesday, March 19th. UNB opened at $36.73 on Tuesday. Union Bankshares has a 52-week low of $36.00 and a 52-week high of $54.00. The company has a market cap of $164.99 million, a price-to-earnings ratio of 16.20 and a beta of 0.19. Union Bankshares (NASDAQ:UNB) last released... 
 

Zacks Investment Research Downgrades DXC Technology (DXC) to Hold

Zacks Investment Research downgraded shares of DXC Technology (NYSE:DXC) from a buy rating to a hold rating in a research report released on Wednesday, Zacks.com reports. According to Zacks, “DXC Technology is benefiting from strength in the Digital business, which expects further boost from the impending acquisition of Luxoft. The company’s traction in the cloud, and partnerships with HCL, AT&T, VMware and Microsoft are likely to drive growth. Cost saving initiatives like the Bionix program are boosting the bottom line. Strong... 
 

Extended Stay America (STAY) Raised to “Hold” at Zacks Investment Research

Zacks Investment Research upgraded shares of Extended Stay America (NYSE:STAY) from a sell rating to a hold rating in a research report released on Wednesday, Zacks.com reports. According to Zacks, “Shares of Extended Stay America have underperformed the industry in the past year. Although the company’s earnings missed the Zacks Consensus Estimate in the first quarter, it surpassed the consensus mark in 11 out of the trailing 15 quarters. Extended Stay America’s efforts to drive revenue per available room (ReVPAR) by providing... 
 

Qiwi (QIWI) Stock Rating Upgraded by Zacks Investment Research

Qiwi (NASDAQ:QIWI) was upgraded by Zacks Investment Research from a “hold” rating to a “strong-buy” rating in a research report issued to clients and investors on Thursday, Zacks.com reports. The brokerage currently has a $19.00 price target on the credit services provider’s stock. Zacks Investment Research‘s price objective indicates a potential upside of 9.57% from the stock’s current price. According to Zacks, “QIWI plc operates as a provider of next generation payment services primarily in Russia... 
 

Franco Nevada (FNV) Rating Lowered to Sector Perform at Royal Bank of Canada

Royal Bank of Canada lowered shares of Franco Nevada (NYSE:FNV) (TSE:FNV) from an outperform rating to a sector perform rating in a research report sent to investors on Wednesday morning, Benzinga reports. Royal Bank of Canada currently has $75.54 price target on the basic materials company’s stock. Several other equities research analysts have also issued reports on the stock. Raymond James reaffirmed an outperform rating and issued a $87.00 price objective on shares of Franco Nevada in a research note on Friday, May 10th. TD Securities... 
 

Seacoast Banking Co. of Florida (SBCF) Lowered to Sell at ValuEngine

ValuEngine lowered shares of Seacoast Banking Co. of Florida (NASDAQ:SBCF) from a hold rating to a sell rating in a research note published on Wednesday morning, ValuEngine reports. SBCF has been the subject of a number of other research reports. FIG Partners lowered Seacoast Banking Co. of Florida from an outperform rating to a market perform rating in a research report on Friday, January 25th. BidaskClub lowered Seacoast Banking Co. of Florida from a hold rating to a sell rating in a research report on Wednesday, February 20th. Hovde Group lowered... 
 

TheStreet Downgrades Godaddy (GDDY) to C

Godaddy (NYSE:GDDY) was downgraded by equities researchers at TheStreet from a “b” rating to a “c” rating in a research report issued to clients and investors on Tuesday, TheStreetRatingsTable reports. Several other research analysts have also recently issued reports on the company. Barclays reaffirmed a “buy” rating and set a $90.00 price objective on shares of Godaddy in a research report on Monday, May 6th. Morgan Stanley set a $95.00 target price on Godaddy and gave the company a “buy” rating... 
 

Cott (COT) Lowered to “Hold” at ValuEngine

ValuEngine lowered shares of Cott (NYSE:COT) (TSE:BCB) from a buy rating to a hold rating in a report published on Wednesday, ValuEngine reports. A number of other analysts have also commented on the stock. Citigroup set a $17.00 target price on shares of Cott and gave the stock a buy rating in a report on Friday, May 3rd. Zacks Investment Research lowered shares of Cott from a hold rating to a sell rating in a report on Monday, April 29th. Finally, TD Securities lowered shares of Cott from an action list buy rating to a buy rating and lowered... 
 

Zacks Investment Research Downgrades SilverCrest Metals (SILV) to Hold

Zacks Investment Research downgraded shares of SilverCrest Metals (NASDAQ:SILV) from a buy rating to a hold rating in a report published on Wednesday morning, Zacks.com reports. According to Zacks, “SilverCrest Metals Inc. focuses on the acquisition, exploration, advancement and development of base mineral and precious metals properties primarily in Mexico. The company’s properties consist of Las Chispas property. SilverCrest Metals Inc. is headquartered in Vancouver, BC. “ SILV has been the topic of a number of other research... 
 

National Securities Reiterates “Buy” Rating for EAGLE POINT CR/COM (ECC)

EAGLE POINT CR/COM (NYSE:ECC)‘s stock had its “buy” rating reissued by research analysts at National Securities in a note issued to investors on Thursday. They currently have a $24.00 price objective on the investment management company’s stock. National Securities’ price objective would indicate a potential upside of 34.15% from the company’s current price. The analysts wrote, “? ECC posted EPS (NII+realized gains per share) of $0.36 compared to our estimate of $0.45 while portfolio cash distributions... 
 

HSBC (HSBC) Stock Rating Upgraded by Goldman Sachs Group

Goldman Sachs Group upgraded shares of HSBC (NYSE:HSBC) from a neutral rating to a buy rating in a research report report published on Wednesday morning, The Fly reports. Several other equities research analysts have also recently weighed in on HSBC. Bank of America cut HSBC from a buy rating to a neutral rating in a research note on Tuesday, February 19th. JPMorgan Chase & Co. reissued a sell rating on shares of HSBC in a research note on Friday, March 8th. Barclays reissued a sell rating on shares of HSBC in a research note on Tuesday, February... 
 

SAGE Therapeutics (SAGE) Receives New Coverage from Analysts at Wedbush

Wedbush began coverage on shares of SAGE Therapeutics (NASDAQ:SAGE) in a research note released on Wednesday morning, The Fly reports. The brokerage issued an outperform rating on the biopharmaceutical company’s stock. Other equities analysts also recently issued research reports about the company. Jefferies Financial Group initiated coverage on SAGE Therapeutics in a research report on Thursday, April 25th. They set a buy rating and a $195.00 price target for the company. ValuEngine downgraded SAGE Therapeutics from a strong-buy rating to... 
 

Edap Tms (EDAP) Downgraded to “Sell” at Zacks Investment Research

Zacks Investment Research downgraded shares of Edap Tms (NASDAQ:EDAP) from a hold rating to a sell rating in a report issued on Wednesday, Zacks.com reports. According to Zacks, “EDAP TMS S.A. develops, produces, markets and distributes minimally invasive medical devices, primarily for the treatment of urological diseases. They currently produce and market devices for treatment of benign prostate hyperplasia and urinary tract stones. They are also developing a third range of products for minimally invasive destruction of certain types of... 
 

CHINA RWY CONST/ADR (CWYCY) Raised to Hold at ValuEngine

ValuEngine upgraded shares of CHINA RWY CONST/ADR (OTCMKTS:CWYCY) from a sell rating to a hold rating in a research note issued to investors on Wednesday morning, ValuEngine reports. Shares of OTCMKTS CWYCY opened at $11.98 on Wednesday. The company has a current ratio of 1.20, a quick ratio of 0.91 and a debt-to-equity ratio of 0.54. CHINA RWY CONST/ADR has a 12 month low of $9.53 and a 12 month high of $14.55. About CHINA RWY CONST/ADR China Railway Construction Corporation Limited, together with its subsidiaries, engages in the construction... 
 

WEST JAPAN RWY/S (WJRYY) Raised to “Hold” at Zacks Investment Research

Zacks Investment Research upgraded shares of WEST JAPAN RWY/S (OTCMKTS:WJRYY) from a sell rating to a hold rating in a research report released on Wednesday, Zacks.com reports. According to Zacks, “West Japan Railway Company engages in the railway transportation business. Its operating segment consists of Transportation, Sales of Goods and Food Services, Real Estate and Other Businesses. Transportation segment provides railway, bus, and ferry services. Distribution segment operates department stores, restaurants, retail and wholesale shops.... 
 

Zacks Investment Research Lowers Second Sight Medical Products (EYES) to Sell

Zacks Investment Research lowered shares of Second Sight Medical Products (NASDAQ:EYES) from a hold rating to a sell rating in a research report sent to investors on Monday morning, Zacks.com reports. According to Zacks, “Second Sight Medical Products, Inc. is a medical device company. It develops, manufactures, and markets implantable prosthetic devices to restore some functional vision to blind patients. The Company provides Argus II system, an implantable neurostimulation device for the treatment of outer retinal degenerations, such as... 
 

Micron Technology (MU) Upgraded to “Hold” by Zacks Investment Research

Micron Technology (NASDAQ:MU) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report released on Tuesday, Zacks.com reports. According to Zacks, “Micron is benefiting from strong growth in managed NAND products, which is boosting revenues of its Mobile Business Unit. Moreover, it expects revival of growth in the second half of calendar 2019 as it anticipates memory demand to improve owing to normalization in most customer inventories by mid-year. Introduction of server processors... 
 

Rigel Pharmaceuticals (RIGL) Downgraded to “Strong Sell” at BidaskClub

Rigel Pharmaceuticals (NASDAQ:RIGL) was downgraded by investment analysts at BidaskClub from a “sell” rating to a “strong sell” rating in a research note issued on Tuesday, BidAskClub reports. A number of other research analysts have also recently commented on the stock. Cantor Fitzgerald reissued a “buy” rating and issued a $9.00 target price on shares of Rigel Pharmaceuticals in a report on Wednesday, January 23rd. HC Wainwright reissued a “buy” rating and issued a $8.00 target price on shares... 
 

Incyte (INCY) Now Covered by Analysts at Credit Suisse Group

Credit Suisse Group assumed coverage on shares of Incyte (NASDAQ:INCY) in a research report sent to investors on Monday morning, BenzingaRatingsTable reports. The firm issued a neutral rating and a $75.00 price target on the biopharmaceutical company’s stock. INCY has been the subject of several other research reports. Royal Bank of Canada lowered Incyte from an outperform rating to a sector perform rating and set a $89.00 target price for the company. in a research report on Wednesday, April 3rd. They noted that the move was a valuation call.... 
 

Broadcom (AVGO) Downgraded by BidaskClub to “Sell”

BidaskClub cut shares of Broadcom (NASDAQ:AVGO) from a hold rating to a sell rating in a report published on Monday, BidAskClub reports. A number of other equities research analysts also recently issued reports on AVGO. Piper Jaffray Companies reissued an overweight rating and set a $310.00 price target on shares of Broadcom in a research report on Thursday, February 14th. Cowen downgraded Broadcom from an outperform rating to a market perform rating and set a $280.00 price target for the company. in a research report on Friday, February 22nd.... 
 

Boot Barn (BOOT) Cut to Hold at Zacks Investment Research

Zacks Investment Research cut shares of Boot Barn (NYSE:BOOT) from a buy rating to a hold rating in a research note issued to investors on Monday, Zacks.com reports. According to Zacks, “Boot Barn Holdings, Inc. operates as a lifestyle retail chain devoted to western and work-related footwear, apparel and accessories. The company’s products include boots, denim, western shirts, cowboy hats, belts and belt buckles, and western-style jewellery and accessories; and rugged footwear, outerwear, overalls, denims, and shirts, as well as safety-toe... 
 

Tcr2 Therapeutics (TCRR) Stock Rating Upgraded by Zacks Investment Research

Tcr2 Therapeutics (NASDAQ:TCRR) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued on Tuesday, Zacks.com reports. According to Zacks, “TCR2 Therapeutics Inc. is a clinical-stage immunotherapy company developing T cell therapies for patients suffering from cancer. Its product candidate includes TC-210, TC-220, TC-410, TC-110 and TC-310 which are in clinical stage. TCR2 Therapeutics Inc. is based in Cambridge, Massachusetts. “ Other analysts also recently... 
 

BidaskClub Lowers ZIX (ZIXI) to Buy

ZIX (NASDAQ:ZIXI) was downgraded by analysts at BidaskClub from a “strong-buy” rating to a “buy” rating in a report issued on Tuesday, BidAskClub reports. A number of other analysts have also recently weighed in on the company. ValuEngine upgraded ZIX from a “buy” rating to a “strong-buy” rating in a research note on Monday, February 4th. Craig Hallum set a $14.00 price target on ZIX and gave the company a “buy” rating in a research note on Friday, May 3rd. Northland Securities restated... 
 

Brookfield Infrastructure Partners (BIP) Rating Increased to Buy at Zacks Investment Research

Brookfield Infrastructure Partners (NYSE:BIP) (TSE:BIP.UN) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report released on Tuesday, Zacks.com reports. The brokerage presently has a $47.00 price target on the utilities provider’s stock. Zacks Investment Research‘s price objective would suggest a potential upside of 12.74% from the company’s previous close. According to Zacks, “BROOKFIELD INFRASTRUCTURE PARTNERS L.P. was established by Brookfield Asset Management... 
 

Fidelity National Financial (FNF) Downgraded by Zacks Investment Research

Zacks Investment Research downgraded shares of Fidelity National Financial (NYSE:FNF) from a buy rating to a hold rating in a report released on Monday morning, Zacks.com reports. According to Zacks, “Fidelity National Title Group, Inc. is a leading provider of title insurance, specialty insurance and claims management services. FNT is one of the nation’s largest title insurance companies through its title insurance underwriters. FNT also provides flood insurance, personal lines insurance and home warranty insurance through it specialty... 
 

CARBO Ceramics (CRR) Cut to “Sell” at Zacks Investment Research

Zacks Investment Research cut shares of CARBO Ceramics (NYSE:CRR) from a hold rating to a sell rating in a research report sent to investors on Monday morning, Zacks.com reports. According to Zacks, “CARBO Ceramics Inc. is an oilfield services technology company that provides industry-leading production enhancement and environmental services solutions. By integrating technologies and intellectual capital to design, build and optimize fractures, CARBO delivers complete production enhancement solutions to help oilfield service companies and... 
 

T2 Biosystems (TTOO) Given “Buy” Rating at HC Wainwright

HC Wainwright restated their buy rating on shares of T2 Biosystems (NASDAQ:TTOO) in a research note issued to investors on Monday morning, AnalystRatings.com reports. The firm currently has a $11.00 price target on the medical equipment provider’s stock. “Our price target is derived from an estimated market value of the firm at $557M, which includes a discounted cash flow analysis based asset value of $600M for T2Dx instrument and test panels, with a 15% discount rate and 0% terminal growth rate, excluding $42M outstanding debt.”,”... 
 

GrubHub (GRUB) Now Covered by Gordon Haskett

Gordon Haskett started coverage on shares of GrubHub (NYSE:GRUB) in a research note published on Monday, BenzingaRatingsTable reports. The firm issued a buy rating and a $75.00 price target on the information services provider’s stock. Other equities research analysts also recently issued reports about the stock. DA Davidson decreased their price objective on shares of GrubHub to $100.00 and set a buy rating for the company in a research note on Friday, February 8th. Mizuho reiterated a buy rating and set a $120.00 price objective on shares... 
 

Abercrombie & Fitch (ANF) Stock Rating Upgraded by Zacks Investment Research

Abercrombie & Fitch (NYSE:ANF) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report released on Tuesday, Zacks.com reports. The firm presently has a $29.00 price objective on the apparel retailer’s stock. Zacks Investment Research‘s price objective points to a potential upside of 19.24% from the stock’s current price. According to Zacks, “Abercrombie surpassed the industry in the past three months driven by strategic capital investments, cost-saving efforts,... 
 

Zacks Investment Research Downgrades Manchester United (MANU) to Hold

Manchester United (NYSE:MANU) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report released on Thursday, Zacks.com reports. According to Zacks, “Manchester United PLC operates a professional sports team. The Company manages the soccer team and all affiliated club activities of the Manchester United Football Club that includes the media network, foundation, fan zone, news and sports features, and team merchandise. Manchester United PLC is based in Manchester, United Kingdom.... 
 

JinkoSolar (JKS) Given a $24.00 Price Target by Roth Capital Analysts

Roth Capital set a $24.00 price objective on JinkoSolar (NYSE:JKS) in a research note published on Monday, TipRanks reports. The firm currently has a buy rating on the semiconductor company’s stock. A number of other research firms also recently weighed in on JKS. ValuEngine upgraded shares of JinkoSolar from a sell rating to a hold rating in a research note on Tuesday, April 23rd. Zacks Investment Research upgraded shares of JinkoSolar from a hold rating to a buy rating and set a $18.00 price target on the stock in a research note on Wednesday,... 
 

NuStar Energy (NS) Stock Rating Lowered by Zacks Investment Research

Zacks Investment Research cut shares of NuStar Energy (NYSE:NS) from a buy rating to a hold rating in a research report report published on Monday, Zacks.com reports. According to Zacks, “NuStar's diversified asset base, strong pipeline of organic growth projects and contribution from acquisitions bode well and have boosted its distributable cash flows of the partnership. NuStar's merger with its general partner, resulting in the elimination of IDRs have creating a more efficient and transparent structure along with boosting the prospects... 
 

UBS Group Reiterates €6.45 Price Target for Banco Bilbao Vizcaya Argentaria (BBVA)

UBS Group set a €6.45 ($7.50) price objective on Banco Bilbao Vizcaya Argentaria (BME:BBVA) in a research note issued to investors on Monday, Borsen Zeitung reports. The firm currently has a buy rating on the stock. A number of other brokerages have also commented on BBVA. Jefferies Financial Group set a €5.70 ($6.63) target price on Banco Bilbao Vizcaya Argentaria and gave the company a neutral rating in a research note on Friday, May 10th. Goldman Sachs Group set a €6.40 ($7.44) target price on Banco Bilbao Vizcaya Argentaria... 
 

Devon Energy (DVN) Research Coverage Started at Wells Fargo & Co

Wells Fargo & Co started coverage on shares of Devon Energy (NYSE:DVN) in a research note released on Monday morning, BenzingaRatingsTable reports. The brokerage issued an outperform rating and a $40.00 price objective on the energy company’s stock. Other research analysts also recently issued reports about the stock. Zacks Investment Research downgraded shares of Devon Energy from a buy rating to a hold rating in a research note on Tuesday, April 2nd. Barclays reiterated a hold rating and set a $36.00 price objective on shares of Devon... 
 

SPX (SPXC) Stock Rating Lowered by Zacks Investment Research

SPX (NYSE:SPXC) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued on Tuesday, Zacks.com reports. According to Zacks, “SPX Corporation (NYSE: SPXC) is, along with its subsidiaries, a diversified, global supplier of infrastructure equipment with scalable growth platforms in heating, ventilation and air conditioning (HVAC), detection and measurement, and engineered solutions. HVAC solutions offered include cooling towers, residential and commercial boilers and... 
 

Medtronic (MDT) Rating Increased to Hold at Zacks Investment Research

Zacks Investment Research upgraded shares of Medtronic (NYSE:MDT) from a sell rating to a hold rating in a report issued on Monday morning, Zacks.com reports. According to Zacks, “The declining CRHF segment raises concern for Medtronic. Escalating costs and expenses continue to weigh on Medtronic’s bottom line. On a positve note, in the past year, shares of Medtronic outperformed its industry. The company is successfully registering sustainable growth across major groups and regions, in addition to displaying successful achievement... 
 

ValuEngine Lowers RPC (RES) to Strong Sell

RPC (NYSE:RES) was downgraded by research analysts at ValuEngine from a “sell” rating to a “strong sell” rating in a research note issued on Thursday, ValuEngine reports. A number of other analysts have also weighed in on the stock. Morgan Stanley cut their price objective on shares of RPC from $12.00 to $9.50 and set an “underperform” rating on the stock in a research note on Thursday, April 25th. Seaport Global Securities upgraded shares of RPC from a “neutral” rating to a “buy” rating... 
 

Cimpress (CMPR) Upgraded by BidaskClub to “Strong-Buy”

Cimpress (NASDAQ:CMPR) was upgraded by analysts at BidaskClub from a “buy” rating to a “strong-buy” rating in a research report issued to clients and investors on Thursday, BidAskClub reports. A number of other equities research analysts have also commented on the company. Barrington Research restated a “buy” rating and set a $100.00 price target on shares of Cimpress in a research report on Friday, May 17th. ValuEngine lowered Cimpress from a “hold” rating to a “sell” rating in a research... 
 

Kopin (KOPN) Downgraded by Zacks Investment Research to Hold

Kopin (NASDAQ:KOPN) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a note issued to investors on Thursday, Zacks.com reports. According to Zacks, “Kopin Corporation is a leading developer and provider of innovative wearable technologies and solutions for integration into head-worn computing and display systems to military, industrial and consumer customers. Kopin’s technologies and solutions are available as components providing individual capabilities or as reference systems... 
 

Susquehanna Bancshares Initiates Coverage on Uber Technologies (UBER)

Analysts at Susquehanna Bancshares initiated coverage on shares of Uber Technologies (NYSE:UBER) in a note issued to investors on Tuesday, Marketbeat reports. The firm set a “neutral” rating and a $42.00 price target on the ride-sharing company’s stock. Susquehanna Bancshares’ price objective indicates a potential upside of 1.82% from the company’s previous close. Other research analysts also recently issued reports about the company. Wedbush reiterated a “buy” rating and set a $65.00 price objective on... 
 

HDFC Bank (HDB) Upgraded to “Hold” by Zacks Investment Research

HDFC Bank (NYSE:HDB) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Tuesday, Zacks.com reports. According to Zacks, “HDFC BANK’s mission is to be a World Class Indian Bank. The Bank’s aim is to build a sound customer franchise across distinct businesses so as to be the preferred provider of banking services in the niche segments that the bank operates in and to achieve healthy growth in profitability, consistent with... 
 

Zacks Investment Research Upgrades Baxter International (BAX) to “Buy”

Zacks Investment Research upgraded shares of Baxter International (NYSE:BAX) from a hold rating to a buy rating in a report issued on Monday, Zacks.com reports. Zacks Investment Research currently has $85.00 price target on the medical instruments supplier’s stock. According to Zacks, “Baxter continues to benefit from its core Advanced Surgery, Renal Care and Acute Therapies units. Baxter’s surgical portfolio is expected to rake in huge profits on the back of products like FLOSEAL Hemostatic Matrix, TISSEEL Fibrin Sealant among... 
 

JPMorgan Chase & Co. Upgrades IPSEN S A/S (IPSEY) to “Neutral”

JPMorgan Chase & Co. upgraded shares of IPSEN S A/S (OTCMKTS:IPSEY) from an underweight rating to a neutral rating in a research report released on Monday, The Fly reports. A number of other equities research analysts have also recently issued reports on the company. ValuEngine cut IPSEN S A/S from a hold rating to a sell rating in a research note on Monday, April 29th. Goldman Sachs Group upgraded IPSEN S A/S from a sell rating to a neutral rating in a research note on Tuesday, February 19th. Shares of IPSEN S A/S stock opened at $31.16 on... 
 

Goldman Sachs Group Upgrades General Dynamics (GD) to Buy

Goldman Sachs Group upgraded shares of General Dynamics (NYSE:GD) from a neutral rating to a buy rating in a report issued on Sunday morning, Benzinga reports. Goldman Sachs Group currently has $204.00 price target on the aerospace company’s stock. GD has been the topic of a number of other research reports. Zacks Investment Research lowered shares of General Dynamics from a hold rating to a sell rating in a research report on Thursday, February 21st. Cowen reaffirmed a buy rating on shares of General Dynamics in a research report on Wednesday,... 
 
© 2006-2019 Ticker Report